Search research articles
Contact Us
Filters
Showing results (31-40 of 185) with videos related to
Page
of 19
Sort By:
The American Journal of Cardiology
|
January 16, 2007
Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives
David J Whellan, Shelby D Reed, Lawrence Liao, et al.
Journal of the American College of Cardiology
|
October 7, 2004
Outcomes in heart failure patients after major noncardiac surgery
Adrian F Hernandez, David J Whellan, Sharon Stroud, et al.
Journal of General Internal Medicine
|
October 2, 2024
Leadership Practices, Organization Structure, and Other Factors Associated with Higher 2022-2023 US News and World Report Ranking
Divya Sankisa, Robert Tatum, Abhiraj Saxena, et al.
Journal of Cardiac Failure
|
May 14, 2013
Associations between Seattle Heart Failure Model scores and health utilities: findings from HF-ACTION
Yanhong Li, Matthew P Neilson, David J Whellan, et al.
Clinical and Translational Science
|
August 20, 2010
Advancing the research mission in an academic department: the creation of a center for translational medicine
Arthur M Feldman, Thomas L Force, David J Whellan, et al.
Heart & Lung : the Journal of Critical Care
|
December 29, 2014
Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds
Vinod Sharma, Lisa D Rathman, Roy S Small, et al.
European Journal of Heart Failure
|
January 28, 2014
Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure
Roy S Small, David J Whellan, Andrew Boyle, et al.
The American Journal of Cardiology
|
May 12, 2009
Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting
Dae Hyun Kim, Constantine Daskalakis, David J Whellan, et al.
Journal of Cardiovascular Pharmacology
|
August 8, 2013
Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study
Cynthia L Green, David J Whellan, Lindsay Lambe, et al.
The American Journal of Cardiology
|
October 9, 2012
Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics
David J Whellan, Shantanu Sarkar, Jodi Koehler, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 185) with videos related to
Sort By:
Page
of 19
The American Journal of Cardiology
|
January 16, 2007
Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives
David J Whellan, Shelby D Reed, Lawrence Liao, et al.
Journal of the American College of Cardiology
|
October 7, 2004
Outcomes in heart failure patients after major noncardiac surgery
Adrian F Hernandez, David J Whellan, Sharon Stroud, et al.
Journal of General Internal Medicine
|
October 2, 2024
Leadership Practices, Organization Structure, and Other Factors Associated with Higher 2022-2023 US News and World Report Ranking
Divya Sankisa, Robert Tatum, Abhiraj Saxena, et al.
Journal of Cardiac Failure
|
May 14, 2013
Associations between Seattle Heart Failure Model scores and health utilities: findings from HF-ACTION
Yanhong Li, Matthew P Neilson, David J Whellan, et al.
Clinical and Translational Science
|
August 20, 2010
Advancing the research mission in an academic department: the creation of a center for translational medicine
Arthur M Feldman, Thomas L Force, David J Whellan, et al.
Heart & Lung : the Journal of Critical Care
|
December 29, 2014
Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds
Vinod Sharma, Lisa D Rathman, Roy S Small, et al.
European Journal of Heart Failure
|
January 28, 2014
Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure
Roy S Small, David J Whellan, Andrew Boyle, et al.
The American Journal of Cardiology
|
May 12, 2009
Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting
Dae Hyun Kim, Constantine Daskalakis, David J Whellan, et al.
Journal of Cardiovascular Pharmacology
|
August 8, 2013
Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study
Cynthia L Green, David J Whellan, Lindsay Lambe, et al.
The American Journal of Cardiology
|
October 9, 2012
Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics
David J Whellan, Shantanu Sarkar, Jodi Koehler, et al.
Page
of 19